ConductScience.org, home

Library / Genes

KRT14: keratin 14

1 protein, 30 patents, 0 drugs, 0 trials, 4,903 NIH grants and 9,382 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKRT14HGNC
Namekeratin 14HGNC
NCBI Gene ID3861NCBI Gene
HGNC IDHGNC:6416HGNC
EnsemblENSG00000186847NCBI Gene
AliasesCK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D, EBS3, EBS4, K14, NFJNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P02533Keratin, type I cytoskeletal 144726Ensembl, GeneID, HGNCUniProt

Patents 30

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-19135P02533Espacenet
WO 2025215055 A12025-10-16108P02533Espacenet
JP 2025517970 A2025-06-12135P02533Espacenet
JP 2024123008 A2024-09-106736P02533Espacenet
US 12024722 B22024-07-02418P02533Espacenet
US 11446398 B22022-09-2042940P02533Espacenet
JP 2022531508 A2022-07-063P02533Espacenet
JP 2022524081 A2022-04-27145911P02533Espacenet
KR 1020220034725 A2022-03-183P02533Espacenet
JP 2021504391 A2021-02-1511P02533Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4903

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant362,025NIH's project files
P30CA008748Cancer Center Support Grant342,025NIH's project files
P01CA022443Molecular Biology and Genetics of Human Tumor Viruses222,025NIH's project files
R37AR027883Cell adhesion and tissue dynamics in the skin202,025NIH's project files
R01AR031737Regulation of Epidermal Development and Differentiation-Renewal192,025NIH's project files
P30CA006973Regional Oncology Research Center162,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant162,025NIH's project files
P30CA014520UW Comprehensive Cancer Center Support152,025NIH's project files
P30CA016086Cancer Center Support Grant152,025NIH's project files
R01EY021797Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency152,025NIH's project files

Papers 9382

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818080PubTator, text miningPubMed
42789213PubTator, text miningPubMed
42780753PubTator, text miningPubMed
42778099PubTator, text miningPubMed
42777382PubTator, text miningPubMed
42734618PubTator, text miningPubMed
42717517PubTator, text miningPubMed
42698624PubTator, text miningPubMed
42684004PubTator, text miningPubMed
42648285PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license